Related Experiment Video
Updated: Oct 5, 2025

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Mupirocin-Resistant Staphylococcus aureus in Iran: A Biofilm Production and Genetic Characteristics
Samira Zamani1, Anis Mohammadi2, Bahareh Hajikhani1
1Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
The spread of mupirocin-resistant Staphylococcus aureus strains in hospitals and communities is a universal challenge. Limited data is available on the genetic features of high-level mupirocin resistant- (HLMUPR-) S. aureus isolates in Tehran. In the present research, we investigated 48 high-level mupirocin resistance S. aureus by antimicrobial activity, virulence analysis, biofilm formation, multilocus sequence typing (MLST), and staphylocoagulase (SC) typing. All the HLMUPR strains were positive for mupA gene. The frequency of multidrug resistance was 97.9%. Twenty-one (43.8%) were toxinogenic with 14 producing pvl (29.2%), 5 tst (10.4%), and two eta (4.2%). Among the HLMUPR isolates, biofilm production was detected in 45 (89.6%) isolates with complete dominance clfB, clfA genes, and a noticeably high frequency fnbA (95.8%), followed by fnbB (93.8%), eno and icaD (each 83.3%), sdrC (81.3%), ebps (79.2%), icaA (75%), sdrD (66.7%), fib (60.4%), sdrE (50%), cna (41.7%), and bap (4.2%). Coagulase typing distinguished isolates into four genotypic patterns including III (50%), II (27.1%), and type IVa (22.9%). A total of three clonal complexes (CCs) and 4 sequence types (STs) including CC/ST22 as the most prevalent (52.1%), CC8/ST239 (20.8%), CC/ST8 (16.7%), and CC/ST5 (10.4%) were identified in current work. According to our analysis, nonbiofilm producer isolates belonged to CC8/ST239 (6.3%) and CC/ST8 (4.2%). Fusidic acid-resistant isolates belonged to CC/ST45 (n = 3) and CC8/ST239 (n = 1). Observations highlighted the circulation of the CC/ST22 HLMUPR S. aureus strains with strong biofilm-production ability in our hospitals, indicating the possibility of transmission of this type between community and hospital.
Insights
High-level mupirocin-resistant Staphylococcus aureus (HLMUPR-SA) strains, particularly CC/ST22, are prevalent in Tehran, exhibiting strong biofilm formation and multidrug resistance. These findings highlight potential community-to-hospital transmission risks.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Mupirocin resistance in Staphylococcus aureus is a growing global health concern.
- Limited data exists on the genetic characteristics of high-level mupirocin-resistant S. aureus (HLMUPR-SA) in Tehran.
Purpose of the Study:
- To investigate the antimicrobial resistance, virulence factors, biofilm formation, and genetic profiles of HLMUPR-SA isolates in Tehran.
- To identify prevalent sequence types (STs) and clonal complexes (CCs) associated with HLMUPR-SA.
Main Methods:
- Antimicrobial susceptibility testing, virulence gene analysis, and biofilm formation assays were performed on 48 HLMUPR-SA isolates.
- Multilocus sequence typing (MLST) and staphylocoagulase (SC) typing were employed for genetic characterization.
- Presence of the mupA gene was confirmed in all resistant strains.
Main Results:
- All HLMUPR-SA strains harbored the mupA gene and exhibited high rates of multidrug resistance (97.9%).
- Significant biofilm production (89.6%) was observed, with dominance of clfB and clfA genes.
- CC/ST22 was the most prevalent clonal type (52.1%), associated with strong biofilm production, followed by CC8/ST239 and CC/ST8.
Conclusions:
- The study identified the circulation of CC/ST22 HLMUPR-SA strains with significant biofilm-forming capacity in Tehran hospitals.
- These findings suggest a potential for transmission of these resistant strains between community and healthcare settings.
- Understanding the genetic makeup and virulence of these strains is crucial for effective infection control strategies.
Related Concept Videos
Biofilms
Development of Antibiotic Resistance

